Showing 1-10 of 737 results for "".
Invasive Melanoma: Incidence, Mortality Continue to Climb
https://practicaldermatology.com/topics/practice-management/invasive-melanoma-incidence-mortality-continue-to-climb/20780/The burden of disease is growing, despite best efforts to combat melanoma.Pregnancy and Melanoma: What We Know About the Risks
https://practicaldermatology.com/topics/practice-management/pregnancy-and-melanoma-what-we-know-about-the-risks/21041/Against a backdrop of conflicting findings, a new study suggests a significant risk associated with melanoma during pregnancy.Panel Supports ATX-101; Melanoma Metastasis Test
https://practicaldermatology.com/topics/practice-management/dermwiretv-panel-supports-atx-101-melanoma-metastasis-test/18959/An FDA Advisory Panel Backs Kythera's ATX-101 for (Submental Fullness) or Double Chin, and a new genetic analysis may enhance SLN Biopsy findings to identify melanoma metastasis.Plus, Dan Siegel, MD, Darrell Rigel, MD, and Neal Bhatia, MD discuss the AAD's proposed dues increase and @NewDermMD launcTNF Inhibitors and the Risk of Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tnf-inhibitors-and-the-risk-of-melanoma/21519/New research offers a deeper look into the potential elevated risk for malignant melanoma from TNF treatment.Melanoma and the Predictive Value of Nevi: Unexpected Findings?
https://practicaldermatology.com/topics/practice-management/melanoma-and-the-predictive-value-of-nevi-unexpected-findings/20936/A new analysis shows that the association between nevi and melanoma is complex.Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of ImlygicRegression in Primary Melanomas: Histologic Factors and Prognosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/regression-in-primary-melanomas-histologic-factors-and-prognosis/21367/Regression was once thought to be a negative prognostic factor in primary melanomas, but new findings suggest otherwise.Update on Melanoma Detection and Screening
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-melanoma-detection-and-screening/19095/From full body skin exams to emerging tape-strip methods for melanoma diagnosis, Laura Ferris, MD talks about the latest research in skin cancer diagnosis with host Joshua Zeichner, MD.Melanoma Rates Rising in Young Adults: Are UV Lamps to Blame?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-rates-rising-in-young-adults-are-uv-lamps-to-blame/21644/New data suggest that the rate of melanoma among individuals age 18 to 39 is on the increase, with poor UV protection strategies implicated.Managing Patients with Atypical Nevi and Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-patients-with-atypical-nevi-and-melanoma/19982/Monitoring patients with several atypical nevi who are at high risk for melanoma is very challenging. Steven Q. Wang, MD offers tips for improving diagnostic accuracy and discusses the role of dermoscopy in detecting melanoma as well as non-melanoma skin cancers at much earlier rates.
- Prev
- Next